Two truncating variants in FANCC and breast cancer risk Journal Article


Authors: Dörk, T.; Peterlongo, P.; Mannermaa, A.; Bolla, M. K.; Wang, Q.; Dennis, J.; Ahearn, T.; Andrulis, I. L.; Anton-Culver, H.; Arndt, V.; Aronson, K. J.; Augustinsson, A.; Freeman, L. E. B.; Beckmann, M. W.; Beeghly-Fadiel, A.; Behrens, S.; Bermisheva, M.; Blomqvist, C.; Bogdanova, N. V.; Bojesen, S. E.; Brauch, H.; Brenner, H.; Burwinkel, B.; Canzian, F.; Chan, T. L.; Chang-Claude, J.; Chanock, S. J.; Choi, J. Y.; Christiansen, H.; Clarke, C. L.; Couch, F. J.; Czene, K.; Daly, M. B.; dos-Santos-Silva, I.; Dwek, M.; Eccles, D. M.; Ekici, A. B.; Eriksson, M.; Evans, D. G.; Fasching, P. A.; Figueroa, J.; Flyger, H.; Fritschi, L.; Gabrielson, M.; Gago-Dominguez, M.; Gao, C.; Gapstur, S. M.; García-Closas, M.; García-Sáenz, J. A.; Gaudet, M. M.; Giles, G. G.; Goldberg, M. S.; Goldgar, D. E.; Guénel, P.; Haeberle, L.; Haiman, C. A.; Håkansson, N.; Hall, P.; Hamann, U.; Hartman, M.; Hauke, J.; Hein, A.; Hillemanns, P.; Hogervorst, F. B. L.; Hooning, M. J.; Hopper, J. L.; Howell, T.; Huo, D.; Ito, H.; Iwasaki, M.; Jakubowska, A.; Janni, W.; John, E. M.; Jung, A.; Kaaks, R.; Kang, D.; Kapoor, P. M.; Khusnutdinova, E.; Kim, S. W.; Kitahara, C. M.; Koutros, S.; Kraft, P.; Kristensen, V. N.; Kwong, A.; Lambrechts, D.; Le Marchand, L.; Li, J.; Lindström, S.; Linet, M.; Lo, W. Y.; Long, J.; Lophatananon, A.; Lubiński, J.; Manoochehri, M.; Manoukian, S.; Margolin, S.; Martinez, E.; Matsuo, K.; Mavroudis, D.; Meindl, A.; Menon, U.; Milne, R. L.; Mohd Taib, N. A.; Muir, K.; Mulligan, A. M.; Neuhausen, S. L.; Nevanlinna, H.; Neven, P.; Newman, W. G.; Offit, K.; Olopade, O. I.; Olshan, A. F.; Olson, J. E.; Olsson, H.; Park, S. K.; Park-Simon, T. W.; Peto, J.; Plaseska-Karanfilska, D.; Pohl-Rescigno, E.; Presneau, N.; Rack, B.; Radice, P.; Rashid, M. U.; Rennert, G.; Rennert, H. S.; Romero, A.; Ruebner, M.; Saloustros, E.; Schmidt, M. K.; Schmutzler, R. K.; Schneider, M. O.; Schoemaker, M. J.; Scott, C.; Shen, C. Y.; Shu, X. O.; Simard, J.; Slager, S.; Smichkoska, S.; Southey, M. C.; Spinelli, J. J.; Stone, J.; Surowy, H.; Swerdlow, A. J.; Tamimi, R. M.; Tapper, W. J.; Teo, S. H.; Terry, M. B.; Toland, A. E.; Tollenaar, R. A. E. M.; Torres, D.; Torres-Mejía, G.; Troester, M. A.; Truong, T.; Tsugane, S.; Untch, M.; Vachon, C. M.; van den Ouweland, A. M. W.; van Veen, E. M.; Vijai, J.; Wendt, C.; Wolk, A.; Yu, J. C.; Zheng, W.; Ziogas, A.; Ziv, E.; ABCTB Investigators; NBCS Collaborators; Dunning, A. M.; Pharoah, P. D. P.; Schindler, D.; Devilee, P.; Easton, D. F.
Article Title: Two truncating variants in FANCC and breast cancer risk
Abstract: Fanconi anemia (FA) is a genetically heterogeneous disorder with 22 disease-causing genes reported to date. In some FA genes, monoallelic mutations have been found to be associated with breast cancer risk, while the risk associations of others remain unknown. The gene for FA type C, FANCC, has been proposed as a breast cancer susceptibility gene based on epidemiological and sequencing studies. We used the Oncoarray project to genotype two truncating FANCC variants (p.R185X and p.R548X) in 64,760 breast cancer cases and 49,793 controls of European descent. FANCC mutations were observed in 25 cases (14 with p.R185X, 11 with p.R548X) and 26 controls (18 with p.R185X, 8 with p.R548X). There was no evidence of an association with the risk of breast cancer, neither overall (odds ratio 0.77, 95%CI 0.44–1.33, p = 0.4) nor by histology, hormone receptor status, age or family history. We conclude that the breast cancer risk association of these two FANCC variants, if any, is much smaller than for BRCA1, BRCA2 or PALB2 mutations. If this applies to all truncating variants in FANCC it would suggest there are differences between FA genes in their roles on breast cancer risk and demonstrates the merit of large consortia for clarifying risk associations of rare variants. © 2019, The Author(s).
Journal Title: Scientific Reports
Volume: 9
ISSN: 2045-2322
Publisher: Nature Publishing Group  
Date Published: 2019-08-29
Start Page: 12524
Language: English
DOI: 10.1038/s41598-019-48804-y
PUBMED: 31467304
PROVIDER: scopus
PMCID: PMC6715680
DOI/URL:
Notes: Vijai Joseph's first and last names are reversed on the original publication -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kenneth Offit
    788 Offit
  2. Vijai Joseph
    211 Joseph